Pages



Tracleer™ (formerly Bosentan)

The first oral endothelin receptor antagonist (ERA) approved for use in PAH patients with WHO Class III or IV symptoms. It is a dual ERA.

Take the Current Poll
View Current Poll Results To Date
View the Poll Archives